MyAverix Finance
NS · Pharmaceuticals
Transchem Ltd (500422)
Pharmaceuticals & Biotechnology
Transchem Ltd (500422) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $4.19B, P/E ratio is 97.55, net margin is 49.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 500422
Transchem Ltd (500422) — FAQ
What is Transchem Ltd's market cap?
Transchem Ltd (500422) has a reported market cap of $4.19B (data as of 2026-07-10).
What is 500422's P/E ratio?
The price-to-earnings (P/E) ratio for Transchem Ltd (500422) is 97.55 (data as of 2026-07-10).
Does Transchem Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Transchem Ltd (500422). Check the MyAverix Finance app for the latest dividend data.
What sector is Transchem Ltd in?
Transchem Ltd (500422) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is 500422 listed on?
500422 is listed on NS.
What is Transchem Ltd's net margin?
Transchem Ltd (500422) reports a net margin of 49.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.